Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Center of excellence
Type 2 Diabetes
Add to Email Alerts
Advisory Board
Rita Rastogi Kalyani, MD, MHS,Associate Professor, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University
School of Medicine, Baltimore, Maryland; Editor-in-Chief, Johns Hopkins Diabetes Guide
Ildiko Lingvay, MD, MPH, MSCS,Professor, Department of Internal Medicine and Department of Endocrinology; Professor, Peter O'Donnell Junior School of Public
Health; Medical Director, Office of Clinical Trials Management, University of Texas Southwestern Medical Center, Dallas, Texas
Anne Peters, MD,Professor, Department of Clinical Medicine; Clinical Scholar, Keck School of Medicine, University of Southern California,
Los Angeles, California
The emergence of new medicinal treatments may have changed the risk-benefit ratio of routine ICD implantation in patients with a severely abnormal LVEF after a heart attack.
Please enter a Recipient Address and/or check the Send me a copy checkbox.
Your email has been sent.
is an Invalid Email Address.
Feedback
Please do not use this form to submit personal or patient medical information or to report adverse drug events. You are encouraged to report adverse drug event information to the FDA.
Your Name is required.
Thank you. Your feedback has been received.
is an Invalid Email Address.
You must provide a message to submit your feedback.